QQ客服 官方微博 反馈留言

	LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis
	Wang, Pei[1]; Chen, Dong[2]; Ma, Hongbing[3]; Li, Yong[4]
刊名	ONCOTARGETS AND THERAPY
	2017
卷号	10页码:5137-5149
关键词	MEG3 miR-21-5p/SOX7 DDP resistance NSCLC
ISSN号	1178-6930
DOI	http://dx.doi.org/10.2147/OTT.S146423
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000413926900001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5182358
专题	河南大学
作者单位	1.[1]Henan Univ, Huaihe Hosp, Dept Cardiothorac Surg, 8 Baobei Rd, Kaifeng 475000, Peoples R China. 2.[2]Henan Univ, Huaihe Hosp, Dept Cardiothorac Surg, 8 Baobei Rd, Kaifeng 475000, Peoples R China. 3.[3]Henan Univ, Huaihe Hosp, Dept Cardiothorac Surg, 8 Baobei Rd, Kaifeng 475000, Peoples R China. 4.[4]Henan Univ, Huaihe Hosp, Dept Cardiothorac Surg, 8 Baobei Rd, Kaifeng 475000, Peoples R China.
推荐引用方式 GB/T 7714	Wang, Pei[1],Chen, Dong[2],Ma, Hongbing[3],et al. LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis[J]. ONCOTARGETS AND THERAPY,2017,10:5137-5149.
APA	Wang, Pei[1],Chen, Dong[2],Ma, Hongbing[3],&Li, Yong[4].(2017).LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis.ONCOTARGETS AND THERAPY,10,5137-5149.
MLA	Wang, Pei[1],et al."LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis".ONCOTARGETS AND THERAPY 10(2017):5137-5149.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。